WGS — GeneDx Holdings Share News
0.000.00%
Last trade - 00:00- $2.09bn
- $2.06bn
- $427.54m
GeneDx Holdings Corp reports results for the quarter ended June 30 - Earnings Summary
GeneDx Q2 revenue beats analyst estimates
U.S. RESEARCH ROUNDUP-Apogee Therapeutics, GE Healthcare, Synopsys
Brief: Genedx Names Mark Gardner President To Lead Its Next Phase Of Scale And Growth
Brief: Alphabet Reports Stake In PayPay And CME Group, Dissolves In Dexcom
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi
GeneDx plunges after trimming annual revenue forecast
GeneDx Q1 revenue misses estimates, cuts FY26 outlook
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines
U.S. RESEARCH ROUNDUP-Dollar General, Keysight Technologies, Teledyne Technologies
U.S. STOCKS ON THE MOVE-AbbVie, CrowdStrike, PayPal
U.S. STOCKS ON THE MOVE-Enhabit, Ethos Technologies, gold miners
U.S. STOCKS ON THE MOVE-Merck, Alphabet, JPMorgan Chase
GeneDx shares rise after Q4 results beat estimates
GeneDx Q4 revenue jumps 27% on genome, exome test demand
Brief: Time Names Genedx CEO Katherine Stueland To The 2026 Time100 Health List Of The World’S Most Influential Leaders In Health
GeneDx prelim Q4 revenue beats expectations
Brief: Genedx Appoints Dr. Linda Genen As Chief Medical Officer
U.S. RESEARCH ROUNDUP-Doordash, Honeywell, Zscaler